Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis

Tropical Medicine and International Health

Volumn 6, Issue 5, 2001, Pages 390-400

  Blum, J ^a   Nkunku, S ^a   Burri, C ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Adverse event; Encephalopathy; Melarsoprol; Sleeping sickness; Symptoms; T. b. gambiense; Treatment; Trypanosomiasis

Indexed keywords

ALCOHOL; MELARSOPROL;

ADULT; AFRICAN TRYPANOSOMIASIS; ALCOHOL CONSUMPTION; ARTICLE; BRAIN DISEASE; BULLOUS SKIN DISEASE; CLINICAL FEATURE; COMA; COMORBIDITY; CONTROLLED STUDY; CONVULSION; DISEASE CLASSIFICATION; FEMALE; FEVER; HEADACHE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALARIA; MALE; MORTALITY; PREDICTION; PSYCHOSIS; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ANGOLA; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MELARSOPROL; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SYNDROME; TIME FACTORS; TREATMENT OUTCOME; TRYPANOCIDAL AGENTS; TRYPANOSOMIASIS, AFRICAN;

PROTOZOA;

EID: 0034986380     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2001.00710.x     Document Type: Article

References (26)

1. Human African trypanosomiasis (T.b. gambiense): A study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy
2. Leishmania and human immunodeficiency virus coinfection: The first 10 years
3. 2 Epidemics of arsenical encephalopathy in the treatment of trypanosomiasis, Uganda, 1992-1993
4. "L'orage liquidien" existe-t-il dasn la trypanosomiase humaine africaine traitée par arsobal-corticoides?
5. Human African trypanosomiasis, contributions of experimental models
6. A case of reactive encephalopathy after the treatment with suramin of first stage sleeping sickness
7. Alternative application of melarsoprol for treatment of T. b. gambiense sleeping sickness. Preliminary results
8. Efficacy of new, concise treatment schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: A randomised trial
9. Reactivation of Chagas' disease in patients with AIDS: Report of three new cases and review of the literature
10. Accidents observes lors du traitement de la trypanosomiase au Congo
11. Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy
12. Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis
13. Chemotherapy of Trypanosoma brucei infection of the central nervous system: The use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies
14. Investigations of the metabolites of the trypanocidal drug melarsoprol
15. A card agglutination test with stained trypanosomes (CATT) for the serological diagnosis of T.b. gambiense trypanosomiasis
16. African trypanosomiasis and drug-induced encephalopathy; risk factors and pathogenesis
17. The treatment of human African trypanosomiasis
18. Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness
19. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness
20. Visceral leishmaniasis and HIV-1 co-infection in southern France
21. Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia
22. Advances in sleeping sickness therapy
23. Present strategies in the treatment of human African trypanosomiasis
24. Post-treatment hind-leg paralysis in mice infected with Trypanosoma brucei brucei: A light microscopic study
25. Control and surveillance of African trypanosomiasis